GLAXOSMITHKLINE PLC - ADR (GSK)
Historical Holders from Q1 2014 to Q3 2025
-
Type / Class
-
Equity / ADR
-
Symbol
-
GSK on NYSE
-
Price per share
-
$43.16
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
2,101
-
Total reported value
-
$90,693
-
% of total 13F portfolios
-
0%
-
Share change
-
-320
-
Value change
-
-$13,811
-
Number of holders
-
5
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
As of 30 Sep 2025,
GLAXOSMITHKLINE PLC - ADR (GSK) has
5
institutional shareholders
filing 13F forms.
They hold
2,101 shares.
.
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q3
|
2,101
|
$90,693
|
-$13,811
|
|
|
$43.16
|
5
|
|
2025 Q2
|
2,421
|
$92,983
|
-$31,852,636
|
|
|
$38.40
|
5
|
|
2025 Q1
|
824,648
|
$31,946,441
|
-$2,420,481
|
|
|
$38.74
|
6
|
|
2024 Q4
|
887,129
|
$30,003,023
|
-$6,268,697
|
|
|
$33.82
|
6
|
|
2024 Q3
|
1,088,929
|
$44,429,787
|
-$7,404,926
|
|
|
$40.88
|
7
|
|
2024 Q2
|
1,269,855
|
$48,887,021
|
-$472,714
|
|
|
$38.50
|
7
|
|
2024 Q1
|
1,282,058
|
$54,906,347
|
+$448,256
|
|
|
$42.87
|
9
|
|
2023 Q4
|
1,271,429
|
$47,119,589
|
-$923,395
|
|
|
$37.06
|
8
|
|
2023 Q3
|
1,295,426
|
$46,959,843
|
+$724,066
|
|
|
$36.25
|
9
|
|
2023 Q2
|
1,287,689
|
$45,456,980
|
-$503,936
|
|
|
$35.64
|
9
|
|
2023 Q1
|
1,289,591
|
$45,884,585
|
+$865,145
|
|
|
$35.58
|
9
|
|
2022 Q4
|
1,308,867
|
$46,357,979
|
-$40,598,166
|
|
|
$35.14
|
13
|
|
2022 Q3
|
2,672,544
|
$78,738,323
|
-$13,603,554,693
|
$0
|
$0
|
$29.43
|
31
|
|
2022 Q2
|
319,727,097
|
$13,922,259,966
|
-$354,564,281
|
$166,082,000
|
$362,617,561
|
$43.53
|
823
|
|
2022 Q1
|
331,147,981
|
$14,434,394,046
|
+$157,492,937
|
$168,047,000
|
$265,611,172
|
$43.56
|
913
|
|
2021 Q4
|
327,398,848
|
$14,443,568,623
|
+$216,623,371
|
$112,061,820
|
$534,880,320
|
$44.10
|
904
|
|
2021 Q3
|
323,687,034
|
$12,374,496,080
|
+$151,235,014
|
$98,258,000
|
$257,270,207
|
$38.21
|
775
|
|
2021 Q2
|
319,518,252
|
$12,729,928,084
|
-$341,563,872
|
$115,014,000
|
$190,223,334
|
$39.82
|
787
|
|
2021 Q1
|
316,555,475
|
$11,315,271,578
|
+$543,119,017
|
$94,152,000
|
$114,951,829
|
$35.69
|
764
|
|
2020 Q4
|
301,924,050
|
$11,117,499,712
|
+$193,375,712
|
$81,434,000
|
$85,919,680
|
$36.80
|
808
|
|
2020 Q3
|
297,985,865
|
$11,216,261,663
|
-$400,087,020
|
$52,782,000
|
$71,695,000
|
$37.64
|
819
|
|
2020 Q2
|
305,392,766
|
$12,461,302,425
|
-$290,663,173
|
$60,874,000
|
$79,129,000
|
$40.79
|
829
|
|
2020 Q1
|
312,433,269
|
$11,849,433,951
|
+$918,476,440
|
$52,909,000
|
$92,604,000
|
$37.89
|
809
|
|
2019 Q4
|
287,890,791
|
$13,530,960,641
|
+$321,723,231
|
$118,699,000
|
$142,820,000
|
$46.99
|
884
|
|
2019 Q3
|
281,834,475
|
$12,033,172,248
|
+$121,566,391
|
$104,054,000
|
$129,256,000
|
$42.68
|
800
|
|
2019 Q2
|
279,154,423
|
$11,177,183,564
|
-$33,533,667
|
$69,486,000
|
$87,363,000
|
$40.02
|
795
|
|
2019 Q1
|
280,555,433
|
$11,729,766,613
|
+$201,281,853
|
$61,644,000
|
$158,936,000
|
$41.79
|
837
|
|
2018 Q4
|
274,187,838
|
$10,483,954,343
|
+$75,971,161
|
$77,592,000
|
$96,191,000
|
$38.21
|
791
|
|
2018 Q3
|
273,484,756
|
$10,984,605,175
|
+$214,789,671
|
$79,704,000
|
$111,858,000
|
$40.17
|
783
|
|
2018 Q2
|
268,204,669
|
$10,811,195,153
|
-$297,360,231
|
$76,211,000
|
$131,499,000
|
$40.31
|
781
|
|
2018 Q1
|
275,706,252
|
$10,772,901,336
|
+$122,331,920
|
$160,098,000
|
$120,644,000
|
$39.07
|
771
|
|
2017 Q4
|
272,953,409
|
$9,684,497,290
|
+$1,015,848,573
|
$96,993,000
|
$95,851,000
|
$35.47
|
753
|
|
2017 Q3
|
242,696,353
|
$9,853,287,513
|
+$527,077,666
|
$78,727,000
|
$120,631,000
|
$40.60
|
736
|
|
2017 Q2
|
229,641,530
|
$9,900,797,982
|
+$361,012,641
|
$72,419,000
|
$142,851,000
|
$43.12
|
772
|
|
2017 Q1
|
221,364,370
|
$9,335,930,183
|
+$526,241,074
|
$73,774,000
|
$114,486,000
|
$42.16
|
779
|
|
2016 Q4
|
208,541,052
|
$8,032,573,648
|
+$51,491,334
|
$115,885,000
|
$121,026,000
|
$38.51
|
756
|
|
2016 Q3
|
206,939,909
|
$8,925,884,857
|
-$126,122,424
|
$85,681,000
|
$131,860,000
|
$43.13
|
727
|
|
2016 Q2
|
210,014,211
|
$9,105,490,089
|
+$231,559,466
|
$100,308,000
|
$143,886,000
|
$43.34
|
730
|
|
2016 Q1
|
205,019,647
|
$8,343,354,550
|
-$335,054,699
|
$73,367,000
|
$114,111,000
|
$40.55
|
711
|
|
2015 Q4
|
215,324,536
|
$8,688,484,219
|
-$122,050,696
|
$103,123,000
|
$193,571,000
|
$40.35
|
708
|
|
2015 Q3
|
217,888,471
|
$8,387,394,599
|
-$436,511,925
|
$104,505,000
|
$167,883,000
|
$38.45
|
692
|
|
2015 Q2
|
232,446,713
|
$9,681,481,087
|
-$828,806,005
|
$201,528,000
|
$204,326,000
|
$41.65
|
708
|
|
2015 Q1
|
250,012,334
|
$11,538,818,302
|
-$115,300,210
|
$208,127,000
|
$104,662,000
|
$46.15
|
726
|
|
2014 Q4
|
253,723,186
|
$10,840,973,794
|
-$554,190,945
|
$114,383,000
|
$186,175,000
|
$42.74
|
717
|
|
2014 Q3
|
264,964,258
|
$12,180,367,650
|
-$644,954,130
|
$130,857,000
|
$177,015,000
|
$45.97
|
693
|
|
2014 Q2
|
277,974,825
|
$14,865,353,653
|
+$862,044,793
|
$69,631,000
|
$93,908,000
|
$53.48
|
712
|
|
2014 Q1
|
261,899,509
|
$13,992,979,930
|
-$180,904,383
|
$62,868,000
|
$97,300,000
|
$53.43
|
704
|